Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far. 

 

Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic.&nbsp;It underscores the challenges facing its new chief executive Mike Doustdar.&nbsp;He spoke to Bloomberg's Guy Johnson about the experience so far.&nbsp;
&nbsp;

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novo Nordisk CEO Mike Doustdar Talks Drug Sales 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2d7de441-899b-4fa7-9e22-b38c00a0570f/transcript

Blue Origin Chief Executive Officer Dave Limp would like to launch eight to 12 flights this year, he said to ED Ludlow in a Bloomberg Television interview ahead of the launch their new Glenn rocket. “We have plenty of hardware to do that,” he said, noting the unprecedented demand for launches.

Blue Origin Chief Executive Officer&nbsp;Dave Limp&nbsp;would like to launch eight to 12 flights this year, he said to ED Ludlow in a Bloomberg Television interview ahead of the launch their new Glenn rocket. &ldquo;We have plenty of hardware to do that,&rdquo; he said, noting the unprecedented demand for launches.

Blue Origin CEO Dave Limp Talks Glenn Rocket

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/48aee020-4299-416b-823c-b43100f198af/transcript

Former Chairman of the Securities and Exchange Commission Gary Gensler joins Bloomberg This Weekend to talk with Christina Ruffini and David Gura about the CFTC's recent investigations into at least two instances over a period of about two weeks where trading volumes within the oil futures market surged shortly before major announcements from President Trump regarding policy pivots related to the war in Iran.

Former Chairman of the Securities and Exchange Commission Gary Gensler joins Bloomberg This Weekend to talk with Christina Ruffini and David Gura about the CFTC's recent investigations into at least two instances over a period of about two weeks where trading volumes within the oil futures market surged shortly before major announcements from President Trump regarding policy pivots related to the war in Iran.

Former SEC Chairman Gary Gensler Talks Recent Insider Trading Investigations

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/da0bc9f6-dc44-415f-8927-b43000d460f3/transcript

Jill Wyant, President and CEO of Madison Air, joins to discuss the company’s IPO plans and the growing opportunity in data center infrastructure, including the buildout of Terafabs. She speaks with Ed Ludlow on "Bloomberg Tech."

Jill Wyant, President and CEO of Madison Air, joins to discuss the company&rsquo;s IPO plans and the growing opportunity in data center infrastructure, including the buildout of Terafabs. She speaks with Ed Ludlow on "Bloomberg Tech."

Madison Air President & CEO Jill Wyant Talks IPO Plans, Data Infrastructure

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4110b45b-16de-42ff-9c99-b42f011222d0/transcript

Novo Nordisk CEO Mike Doustdar Talks Drug Sales

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips